beps63 posted this 1 hour ago on BelliCapelli. This seems the abstract of the scientific research which will be presented/introduced at SITRI's next month. The participation of Brotzu (and probably FIDIA too) was confirmed by my dermatologist on the thread, who is the president of SITRI's association.
Translation: (by me with the help of Google)
Abstract Naples 14/4/18
'Liposomal solution containing DGLA, Equol and Carnitine for the treatment of androgenetic alopecia.'
G.Brotzu, G. Brotzu, F. Consolaro, C. Secchieri.
Bioricerca snc, Fidia Farmaceuticici SPA,
Presents Giovanni Brotzu
In 2012 KITAGAWA e coll. showed that cationic liposomes, with a diameter of around 100 nm, could easily penetrate through the dermis and thereby improving the release of lipophilic molecules. Based on this research, it was studied if it was possible to use liposomes for the release of molecules able to stimulate endothelial cells of the hair bulbs. Previously it was observed that PGE1 was able to stimulate endothelial cells and to increase tissue capillarization.
It is known that di-homo-gamma-linoleic acid (DGLA) is the biochemical precursor of PGE1. In fact it is transformed by cyclooxygenase into PGE1. It has been ascertained that in the various forms of alopecia there is a diminished capillarization and therefore, a deficit in the functionality of the capillaries which supply the hair bulbs of both O2 and the other molecules.
The other molecules transported by liposomes are: the Equol and the Carnitine.
The Equol is a flavonoid that inhibits the 5α-reductase enzyme by preventing testosterone from turning into dihydrotestosterone; carnitine promotes the beta-oxidation of the circulating lipid chains and increases the local metabolism.
Dihydrotestosterone is one of the main culprits of Androgenetic Alopecia.
Tests performed: the efficacy of two liposomal lotions was tested on 30 male subjects and 30 female subjects. The following checks were performed: efficacy against hair loss by results of phototrichogram and wash test, evaluation of hair resistance by Pull Test, clinical evaluation of tolerability and subjective evaluation of the effectiveness and tolerability of the lotion. Tests were performed at the beginning of treatment (T0) and after 1 (T1), 3 (T3) and 6 (T6) months of treatment.
The results showed that a daily and constant application of the above mentioned lotion favors the growth of new hair and reduce the fall of existing hair. In addition, the hair becomes more resistant and the lotion is well tolerated by the subjects.
Sorry for eventual grammar errors. I would like to say that we know that Equol does NOT inhibit 5AR but binds to DHT itself, so please don't make boring comments stating that, also because in a month we could possibly know everything.
There are other things I wanted to say more, but right know that the congress is confirmed, I guess writing tons of lines here is kinda useless.